Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects
Clinical trial NCT04621318 · COMPLETED
Trial details
- NCT number
- NCT04621318
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2022-11-09
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.